Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2009 07:00 ET | Source: Human Genome Sciences, Inc.

Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile

ROCKVILLE, MD--(Marketwire - February 2, 2009) - Human Genome Sciences, Inc. (NASDAQ: HGSI) today announced that it has begun delivery of 20,000 doses of its human monoclonal antibody drug...